Update on therapeutic management of idiopathic pulmonary fibrosis
about
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanibMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisLevels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.Lung Beractant Increases Free Cytosolic Levels of Ca2+ in Human Lung FibroblastsAldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway.A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.Mesenchymal stem cells in idiopathic pulmonary fibrosis.Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.Metabolic Disorders in Chronic Lung Diseases.Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.Effect of pirfenidone on wound healing in lung transplant patients.Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
P2860
Q26771647-D5FB17A9-06BA-4C63-9DC3-C5BFBCB326BCQ27348347-7A137BF5-66DB-4609-9E63-3C76BC909294Q30398970-F5DBFFB2-0965-439A-BC1C-98A97FB8E5F2Q35730407-C420196B-F111-4129-958C-AD4463CC6205Q36072394-26A96390-BB9E-47F2-983E-2522EA5F0FB8Q37628170-BF375F1A-296B-455F-88B7-FF1DAB211B42Q38614634-FD95CD3E-1F16-4683-A954-F7123D010BD6Q38773552-29FE6212-D2F0-43AA-9B67-79DF29A7E010Q41159764-64D2EA5C-A92E-4447-8203-821F27AA9194Q47123592-DD5D8888-C01C-46A4-989E-60DA3C665093Q47680958-532F6A81-0DF6-4376-BE96-CB16A4D64684Q49795481-CAF11FCB-6F98-41D9-83B2-E703B15594AEQ50334242-F6712DE1-DE6D-4BB2-BDCC-92DA7109F213Q51410548-27D7A2C1-C474-4B84-858C-FC9223A162B7Q55339490-7B2C5AAE-8243-4A13-BCA4-F20A8EAC62C5Q55379594-779D3EA1-2972-4269-9E6E-1C7CA0466EFCQ58774992-DF590676-8000-4F05-9050-A3BB605B15D3
P2860
Update on therapeutic management of idiopathic pulmonary fibrosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Update on therapeutic management of idiopathic pulmonary fibrosis
@ast
Update on therapeutic management of idiopathic pulmonary fibrosis
@en
Update on therapeutic management of idiopathic pulmonary fibrosis
@nl
type
label
Update on therapeutic management of idiopathic pulmonary fibrosis
@ast
Update on therapeutic management of idiopathic pulmonary fibrosis
@en
Update on therapeutic management of idiopathic pulmonary fibrosis
@nl
prefLabel
Update on therapeutic management of idiopathic pulmonary fibrosis
@ast
Update on therapeutic management of idiopathic pulmonary fibrosis
@en
Update on therapeutic management of idiopathic pulmonary fibrosis
@nl
P2093
P2860
P356
P1476
Update on therapeutic management of idiopathic pulmonary fibrosis
@en
P2093
Argyris Tzouvelekis
Francesco Bonella
Paolo Spagnolo
P2860
P304
P356
10.2147/TCRM.S69716
P407
P577
2015-03-03T00:00:00Z